These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 30684021)

  • 1. Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia.
    Yousef AM; Farhad R; Alshamaseen D; Alsheikh A; Zawiah M; Kadi T
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):755-762. PubMed ID: 30684021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Folate-Related Gene Polymorphisms on High-Dose Methotrexate-Related Toxicity and Prognosis in Turkish Children with Acute Lymphoblastic Leukemia.
    Yazıcıoğlu B; Kaya Z; Güntekin Ergun S; Perçin F; Koçak Ü; Yenicesu İ; Gürsel T
    Turk J Haematol; 2017 Jun; 34(2):143-150. PubMed ID: 27094381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gene polymorphisms on delayed MTX clearance, toxicity, and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia.
    Zhou Y; He H; Ding L; Wang T; Liu X; Zhang M; Zhang A; Fu J
    Eur J Pediatr; 2024 Feb; 183(2):581-590. PubMed ID: 37851084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of genetic polymorphism on toxicity and pharmacokinetics of methotrexate in Egyptian adult patients with leukaemia or lymphoma.
    Shendy K; Abdelkawy K; Ali AA; Belal F; Abdelhakiem M; Magdy G; Anber N; Elbarbry F
    Xenobiotica; 2024 Feb; 54(2):95-105. PubMed ID: 38381003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304).
    Ulrich CM; Rankin C; Toriola AT; Makar KW; Altug-Teber Ö; Benedetti JK; Holmes RS; Smalley SR; Blanke CD; Lenz HJ
    Cancer; 2014 Nov; 120(21):3329-3337. PubMed ID: 25041994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis.
    Davis LA; Polk B; Mann A; Wolff RK; Kerr GS; Reimold AM; Cannon GW; Mikuls TR; Caplan L
    Clin Exp Rheumatol; 2014; 32(3):324-32. PubMed ID: 24447348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association study of putative functional single nucleotide polymorphisms of genes in folate metabolism and spina bifida.
    Martinez CA; Northrup H; Lin JI; Morrison AC; Fletcher JM; Tyerman GH; Au KS
    Am J Obstet Gynecol; 2009 Oct; 201(4):394.e1-11. PubMed ID: 19683694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics.
    Kager L; Cheok M; Yang W; Zaza G; Cheng Q; Panetta JC; Pui CH; Downing JR; Relling MV; Evans WE
    J Clin Invest; 2005 Jan; 115(1):110-7. PubMed ID: 15630450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of
    Karschnia P; Kurz SC; Brastianos PK; Winter SF; Gordon A; Jones S; Pisapia M; Nayyar N; Tonn JC; Batchelor TT; Plotkin SR; Dietrich J
    Neurology; 2023 Oct; 101(17):e1741-e1746. PubMed ID: 37527941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry.
    Salazar J; Garcia-Planella E; Fernández-Clotet A; Esteve M; Gisbert JP; Busquets D; Lucendo A; Márquez L; Guardiola J; Martín-Arranz MD; Iglesias E; Monfort D; Villoria A; Cañete F; Bell O; Ricart E; Zabana Y; Chaparro M; Domènech E; Gordillo J;
    Br J Clin Pharmacol; 2024 May; 90(5):1301-1311. PubMed ID: 38369687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the
    Guo Q; Sun JL; Li R; Li X
    Int J Gen Med; 2024; 17():1221-1231. PubMed ID: 38559593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients.
    Holmboe L; Andersen AM; Mørkrid L; Slørdal L; Hall KS
    Br J Clin Pharmacol; 2012 Jan; 73(1):106-14. PubMed ID: 21707700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate pathway gene polymorphisms, maternal folic acid use, and risk of childhood acute lymphoblastic leukemia.
    Milne E; Greenop KR; Scott RJ; Haber M; Norris MD; Attia J; Jamieson SE; Miller M; Bower C; Bailey HD; Dawson S; McCowage GB; de Klerk NH; van Bockxmeer FM; Armstrong BK
    Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):48-56. PubMed ID: 25395472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the plasma methotrexate concentration during high-dose methotrexate therapy in childhood acute lymphoblastic leukemia.
    Liao C; Nie J; Xu XJ; Zhang JY; Xu WQ; Song H; Shen HP; Shen DY; Zhao FY; Liang J; Miao J; Tang YM
    Leuk Lymphoma; 2024 Jan; 65(1):91-99. PubMed ID: 37820046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate.
    Pitakkitnukun P; Pongpitakmetha T; Suttichet TB; Sukkummee W; Chariyavilaskul P; Polprasert C
    Sci Rep; 2024 Apr; 14(1):9695. PubMed ID: 38678107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 19-base pair deletion polymorphism of the dihydrofolate reductase (DHFR) gene: maternal risk of Down syndrome and folate metabolism.
    Mendes CC; Biselli JM; Zampieri BL; Goloni-Bertollo EM; Eberlin MN; Haddad R; Riccio MF; Vannucchi H; Carvalho VM; Pavarino-Bertelli EC
    Sao Paulo Med J; 2010 Jul; 128(4):215-8. PubMed ID: 21120433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia.
    Zobeck M; Bernhardt MB; Kamdar KY; Rabin KR; Lupo PJ; Scheurer ME
    Pharmacotherapy; 2023 Mar; 43(3):205-214. PubMed ID: 36764694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with high-dose methotrexate induced toxicities.
    Li W; Mo J; Yang Z; Zhao Z; Mei S
    Expert Opin Drug Metab Toxicol; 2024 Apr; 20(4):263-274. PubMed ID: 38501267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLCO1B1 *15 allele is associated with methotrexate-induced nausea in pediatric patients with inflammatory bowel disease.
    Mehta RS; Taylor ZL; Martin LJ; Rosen MJ; Ramsey LB
    Clin Transl Sci; 2022 Jan; 15(1):63-69. PubMed ID: 34423897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms and their association with methotrexate polyglutamates during maintenance treatment in Korean children and young adults with acute lymphoblastic leukemia.
    Choi R; Kim MJ; Ju HY; Lee JW; Lee SY
    Eur J Pharm Sci; 2024 Aug; 202():106878. PubMed ID: 39159789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.